4.4 Article

Severe Influenza in 33 US Hospitals, 2013-2014: Complications and Risk Factors for Death in 507 Patients

期刊

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
卷 36, 期 11, 页码 1251-1260

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/ice.2015.170

关键词

-

资金

  1. National Institute of Allergy and Infectious Diseases [K23 AI095361]

向作者/读者索取更多资源

BACKGROUND. Influenza A (H1N1) pdm09 became the predominant circulating strain in the United States during the 2013-2014 influenza season. Little is known about the epidemiology of severe influenza during this season. METHODS. A retrospective cohort study of severely ill patients with influenza infection in intensive care units in 33 US hospitals from September 1, 2013, through April 1, 2014, was conducted to determine risk factors for mortality present on intensive care unit admission and to describe patient characteristics, spectrum of disease, management, and outcomes. RESULTS. A total of 444 adults and 63 children were admitted to an intensive care unit in a study hospital; 93 adults (20.9%) and 4 children (6.3%) died. By logistic regression analysis, the following factors were significantly associated with mortality among adult patients: older age (>65 years, odds ratio, 3.1 [95% CI, 1.4-6.9], P=.006 and 50-64 years, 2.5 [1.3-4.9], P=.007; reference age 18-49 years), male sex (1.9 [1.1-3.3], P=.031), history of malignant tumor with chemotherapy administered within the prior 6 months (12.1 [3.9-37.0], P<.001), and a higher Sequential Organ Failure Assessment score (for each increase by 1 in score, 1.3 [1.2-1.4], P<.001). CONCLUSION. Risk factors for death among US patients with severe influenza during the 2013-2014 season, when influenza A (H1N1) pdm09 was the predominant circulating strain type, shifted in the first postpandemic season in which it predominated toward those of a more typical epidemic influenza season.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Improving Outpatient Antibiotic Prescribing for Respiratory Tract Infections in Primary Care: A Stepped-Wedge Cluster Randomized Trial

Lauren Dutcher, Kathleen Degnan, Afia B. Adu-Gyamfi, Ebbing Lautenbach, Leigh Cressman, Michael Z. David, Valerie Cluzet, Julia E. Szymczak, David A. Pegues, Warren Bilker, Pam Tolomeo, Keith W. Hamilton

Summary: A provider-targeted intervention implemented in primary care practices can effectively reduce antibiotic prescribing for respiratory tract infections without affecting prescribing for infections that likely require antibiotics.

CLINICAL INFECTIOUS DISEASES (2022)

Article Public, Environmental & Occupational Health

Development and validation of antibiotic stewardship metrics for outpatient respiratory tract diagnoses and association of provider characteristics with inappropriate prescribing

Kathleen O. Degnan, Valerie Cluzet, Michael Z. David, Lauren Dutcher, Leigh Cressman, Ebbing Lautenbach, Keith W. Hamilton

Summary: This retrospective cohort study aimed to determine metrics and provider characteristics associated with inappropriate antibiotic prescribing for respiratory tract diagnoses. The study found that metrics utilizing proportion prescribing for respiratory tract diagnoses for which antibiotics are almost never required and proportion prescribing for any respiratory tract diagnoses were most strongly associated with inappropriate prescribing. Advanced practice providers (APPs) and clinicians with family medicine training, board certification in 1997 or later, and who worked in non-teaching or non-urban practices had higher proportions of inappropriate prescribing. These findings could inform interventions to improve prescribing and track inappropriate prescribing efficiently.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Article Public, Environmental & Occupational Health

Healthcare microenvironments define multidrug-resistant organism persistence

Brendan J. Kelly, Selamawit Bekele, Sean Loughrey, Elizabeth Huang, Pam Tolomeo, Michael Z. David, Ebbing Lautenbach, Jennifer H. Han, Matthew J. Ziegler

Summary: The position of patients and wastewater sites is related to the detection of multidrug-resistant organisms in the healthcare environment. Some resistant bacteria are more likely to be detected close to patients, while others are more likely to be detected far from patients.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Article Public, Environmental & Occupational Health

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) surface contamination in staff common areas and impact on healthcare worker infection: Prospective surveillance during the coronavirus disease 2019 (COVID-19) pandemic

Helen L. Zhang, Brendan J. Kelly, Michael Z. David, Ebbing Lautenbach, Elizabeth Huang, Selamawit Bekele, Pam Tolomeo, Emily Reesey, Sean Loughrey, David Pegues, Matthew J. Ziegler

Summary: This study prospectively surveyed the contamination of SARS-CoV-2 RNA in staff common areas of an acute-care hospital. It found an increasing prevalence of surface contamination over time. However, adjusting for patient census or community incidence of COVID-19, the proportion of contaminated surfaces did not predict healthcare worker infection on study units.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Article Oncology

Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia

William Alegria, Bernard L. Marini, Kevin Sellery Gregg, Dale Lee Bixby, Anthony Perissinotti, Jerod Nagel

Summary: This study evaluated the safety and effectiveness of antibiotic de-escalation in patients with acute myeloid leukemia who had fever and ongoing neutropenia. The results showed that de-escalation strategy reduced the days of therapy for intravenous antipseudomonal beta-lactams and decreased the incidence of Clostridioides difficile colitis without adversely impacting patient outcomes.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

Article Public, Environmental & Occupational Health

Patients' experiences and compliance with preoperative screening and decolonization

Ethan Wilson, Alexandre R. Marra, Melissa Ward, Laura Chapin, Stephanie Boulden, Timothy C. Ryken, Lynne C. Jones, Loreen A. Herwaldt

Summary: Background: More information about patients' experiences with pre-surgical screening and decolonization protocols is needed to enhance adherence. Methods: Patients undergoing orthopedic, neurosurgical, or cardiac operations at multiple hospitals were surveyed to assess their experiences. Results: Respondents at one hospital were more likely to report using decolonization agents and feeling adequately informed about infection prevention. Patients varied in their concern and willingness to prevent infections and their assessments of preoperative information. Conclusion: Improving adherence requires tailoring preoperative processes, education, and prophylaxis to patients' needs and desires.

AMERICAN JOURNAL OF INFECTION CONTROL (2023)

Article Immunology

Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial

Rebekah W. Moehring, Michael E. Yarrington, Bobby G. Warren, Yuliya Lokhnygina, Erica Atkinson, Allison Bankston, Julia Collucio, Michael Z. David, Angelina E. Davis, Janice Davis, Brandon Dionne, April P. Dyer, Travis M. Jones, Michael Klompas, David W. Kubiak, John Marsalis, Jacqueline Omorogbe, Patricia Orajaka, Alice Parish, Todd Parker, Jeffrey C. Pearson, Tonya Pearson, Christina Sarubbi, Christian Shaw, Justin Spivey, Robert Wolf, Rebekah H. Wrenn, Elizabeth S. Dodds Ashley, Deverick J. Anderson

Summary: This randomized trial evaluated the effect of an opt-out intervention on suspected sepsis in hospitalized adults. The intervention led to a decrease in unnecessary antibiotic use and showed similar outcomes in terms of antibiotic treatment days for patients who continued antibiotic therapy. No evidence of harm was found.

CLINICAL INFECTIOUS DISEASES (2023)

Letter Biophysics

Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients

John Coda, Kadee Raser, Sarah M. Anand, Monalisa Ghosh, Kevin Gregg, Jinju Li, John J. Maciejewski, Attaphol Pawarode, Mary M. Riwes, Christina Tillman, Avery Polk, Malathi Kandarpa, Moshe Talpaz, Sung Won Choi, Gregory A. Yanik, John M. Magenau, Matthew J. Pianko

BONE MARROW TRANSPLANTATION (2023)

Review Biochemistry & Molecular Biology

Staphylococcus aureus Genomic Analysis and Outcomes in Patients with Bone and Joint Infections: A Systematic Review

Kevin Bouiller, Michael Z. Z. David

Summary: A systematic literature review was conducted to assess the association between S. aureus genes and outcomes in patients with bone and joint infections. The results showed that PVL genes were associated with poor outcomes in children, while no specific genes were found to have similar associations in adults. Further studies with larger sample sizes and homogeneous patient populations are needed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Multidisciplinary Sciences

Real world effectiveness of tixagevimab/cilgavimab (Evusheld) in the Omicron era

Benjamin Chen, Nina Haste, Nancy Binkin, Nancy Law, Lucy E. E. Horton, Nancy Yam, Victor Chen, Shira Abeles

Summary: Tixagevimab/cilgavimab (T/C) received Emergency Use Authorization for pre-exposure prophylaxis of COVID-19, but its effectiveness in the Omicron era is unclear. A retrospective study found that T/C recipients who contracted COVID-19 after receiving the drug were one-fourth as likely to be hospitalized compared to those infected prior to T/C.

PLOS ONE (2023)

Article Immunology

Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series

Madison Breeden, Samuel L. Aitken, Ji Hoon Baang, Misty Gravelin, Daniel R. Kaul, Adam S. Lauring, Lindsay A. Petty, Kevin S. Gregg

Summary: Immunocompromised patients with B-cell deficiencies, who received B-cell-depleting therapies for B-cell malignancies, developed persistent SARS-CoV-2 infection. Symptoms resolved following an extended course of nirmatrelvir/ritonavir.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Microbiology

Common antibiotics, azithromycin and amoxicillin, affect gut metagenomics within a household

Jessica Chopyk, Ana Georgina Cobian Guemes, Claudia Ramirez-Sanchez, Hedieh Attai, Melissa Ly, Marcus B. Jones, Roland Liu, Chenyu Liu, Kun Yang, Xin M. Tu, Shira R. Abeles, Karen Nelson, David T. Pride

Summary: This study investigated the effects of two commonly used antibiotics, azithromycin and amoxicillin, on the human gut microbiome. The results showed clear and sustained impacts of these antibiotics on the gut microbial community, particularly the significant alterations in Bifidobacterium species in response to azithromycin. Importantly, no significant changes were observed in other members of the microbial community compared to the control group.

BMC MICROBIOLOGY (2023)

Article Immunology

An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections

Krishna Rao, Qianzi Zhao, Justin Bell, Jay Krishnan, Oryan Henig, Jolene Daniel, Kara Sawaya, Owen Albin, John P. Mills, Lindsay A. Petty, Kevin Gregg, Daniel Kaul, Anurag N. Malani, Jason Pogue, Keith S. Kaye

Summary: This study compares the efficacy of fidaxomicin and vancomycin in the treatment of CDI with concomitant antibiotic use. The cure rate was slightly higher in the fidaxomicin group, but the result did not reach statistical significance.

CLINICAL INFECTIOUS DISEASES (2023)

Article Critical Care Medicine

Defibrotide Therapy for SARS-CoV-2 ARDS

David Frame, Gianni B. Scappaticci, Thomas M. Braun, Mary Maliarik, Thomas H. Sisson, Steven W. Pipe, Daniel A. Lawrence, Paul G. Richardson, Michael Holinstat, Robert C. Hyzy, Daniel R. Kaul, Kevin S. Gregg, Vibha N. Lama, Gregory A. Yanik

Summary: This study demonstrates the safety and tolerability of defibrotide for the management of severe SARS-CoV-2 infections, with no reported hemorrhagic or thrombotic complications. Although three patients died, there were promising outcomes with nine patients remaining alive for a long period of time.
Letter Medicine, General & Internal

SARS-CoV-2 Infection in Vaccinated Health Care Workers REPLY

Lucy E. Horton, Shira R. Abeles, Francesca J. Torriani

NEW ENGLAND JOURNAL OF MEDICINE (2022)

暂无数据